Real-world evidence of nivolumab monotherapy in advanced renal cell carcinoma from a multicenter retrospective cohort study by the Spanish Genitourinary Oncology Group.
Saved in:
| Title: | Real-world evidence of nivolumab monotherapy in advanced renal cell carcinoma from a multicenter retrospective cohort study by the Spanish Genitourinary Oncology Group. |
|---|---|
| Authors: | Fernández-Díaz N; Department of Medical Oncology, University Clinical Hospital of Santiago de Compostela (SERGAS), Santiago de Compostela, Spain.; Translational Medical Oncology Group (ONCOMET), Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Spain.; University of Santiago de Compostela (USC), Santiago de Compostela, Spain., Mateos-González M; Department of Medical Oncology, University Clinical Hospital of Santiago de Compostela (SERGAS), Santiago de Compostela, Spain.; Translational Medical Oncology Group (ONCOMET), Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Spain., Pertejo-Fernández A; Department of Medical Oncology, Hospital Universitario La Paz - IdiPAZ, Madrid, Spain., Cacho-Lavín JD; Department of Medical Oncology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain., Juan-Fita MJ; Department of Medical Oncology, Fundación Instituto Valenciano de Oncología (IVO), Valencia, Spain., Chirivella-González I; Department of Medical Oncology, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain., Arruti-Ibarbia M; Department of Medical Oncology, Hospital Galdakao-Usansolo, Bizkaia, Spain., Fernández-Calvo O; Department of Medical Oncology, Complejo Hospitalario Universitario de Ourense, Ourense, Spain., Fernández-Núñez N; Department of Medical Oncology, Hospital Universitario Lucus Augusti, Lugo, Spain., Méndez-Vidal MJ; Department of Medical Oncology, Hospital Universitario Reina Sofía, Maimonides Institute for Biomedical Research of Córdoba (IMIBIC), Córdoba, Spain., Lázaro-Quintela M; Department of Medical Oncology, Complejo Hospitalario Universitario de Vigo, Vigo, Spain., Molina-Díaz A; Department of Medical Oncology, Complejo Hospitalario Universitario de A Coruña, A Coruña, Spain., Del Pozo-Alonso N; Department of Medical Oncology, Hospital Universitario del Vinalopó, Elche, Alicante, Spain., Etxaniz-Ulazia O; Department of Medical Oncology, Catalan Institute of Oncology (ICO), Hospital Germans Trias I Pujol, Badalona, Barcelona, Spain., García-Acuña SM; Department of Pathology, University Clinical Hospital of Santiago de Compostela (SERGAS), University of Santiago de Compostela (USC), Santiago de Compostela, Spain., Betancor YZ; Translational Medical Oncology Group (ONCOMET), Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Spain.; University of Santiago de Compostela (USC), Santiago de Compostela, Spain.; Genomes and Disease, Centre for Research in Molecular Medicine and Chronic Diseases (CiMUS), University of Santiago de Compostela (USC), Santiago de Compostela, Spain., Azueta-Etxebarria A; Department of Pathology, Hospital Universitario Marques de Valdecilla, IDIVAL, Santander, Spain.; Department of Pathology, Basurto University Hospital, Translational Prostate Cancer Research Lab, CIC bioGUNE-Basurto, Biocruces Bizkaia Health Research Institute, Bilbao, Spain., Calatrava-Fons A; Department of Pathology, Fundación Instituto Valenciano de Oncología (IVO), Valencia, Spain., Lombardía-Rodríguez H; Translational Medical Oncology Group (ONCOMET), Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Spain.; University of Santiago de Compostela (USC), Santiago de Compostela, Spain., Alarcón-Molero L; Department of Pathology, Hospital Clínico Universitario de Valencia, Valencia, Spain.; Department of Pathology, General Hospital of Valdepeñas, Ciudad Real, Spain., Etxegarai-Ganboa L; Department of Pathology, Hospital Galdakao-Usansolo, Bizkaia, Spain., Antón-Cameselle A; Translational Medical Oncology Group (ONCOMET), Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Spain.; University of Santiago de Compostela (USC), Santiago de Compostela, Spain., Bello-Giz JA; Department of Pathology, Complejo Hospitalario Universitario de Ourense, Ourense, Spain., Neira-De Paz CM; Department of Pathology, Hospital Universitario Lucus Augusti, Lugo, Spain., Cabaleiro T; Fundación Pública Galega Instituto de Investigación Sanitaria de Santiago de Compostela, University Clinical Hospital of Santiago de Compostela, Santiago de Compostela, Spain., González-Serrano T; Department of Pathology, Hospital Universitario Reina Sofía, Maimonides Institute for Biomedical Research of Córdoba (IMIBIC), Córdoba, Spain., Ortiz-Rey JA; Department of Pathology, Complejo Hospitalario Universitario de Vigo, Vigo, Spain., Sacristán-Lista F; Department of Pathology, Complejo Hospitalario Universitario de A Coruña, A Coruña, Spain., García-Rubín S; Translational Medical Oncology Group (ONCOMET), Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Spain., Ortega E; Department of Pathology, Hospital Universitario del Vinalopó, Elche, Alicante, Spain., Carrato-Moñino C; Department of Pathology, Hospital Germans Trias I Pujol, Badalona, Barcelona, Spain., Aguín-Losada S; Department of Medical Oncology, University Clinical Hospital of Santiago de Compostela (SERGAS), Santiago de Compostela, Spain.; Translational Medical Oncology Group (ONCOMET), Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Spain., León-Mateos L; Department of Medical Oncology, University Clinical Hospital of Santiago de Compostela (SERGAS), Santiago de Compostela, Spain.; Translational Medical Oncology Group (ONCOMET), Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Spain.; University of Santiago de Compostela (USC), Santiago de Compostela, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain., García-González J; Department of Medical Oncology, University Clinical Hospital of Santiago de Compostela (SERGAS), Santiago de Compostela, Spain.; Translational Medical Oncology Group (ONCOMET), Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain., Pinto-Marín Á; Department of Medical Oncology, Hospital Universitario La Paz - IdiPAZ, Madrid, Spain., Duran I; Department of Medical Oncology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain., López-López R; Department of Medical Oncology, University Clinical Hospital of Santiago de Compostela (SERGAS), Santiago de Compostela, Spain.; Translational Medical Oncology Group (ONCOMET), Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Spain.; University of Santiago de Compostela (USC), Santiago de Compostela, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain., Anido-Herranz U; Department of Medical Oncology, University Clinical Hospital of Santiago de Compostela (SERGAS), Santiago de Compostela, Spain.; Translational Medical Oncology Group (ONCOMET), Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Spain., Ruiz-Bañobre J; Department of Medical Oncology, University Clinical Hospital of Santiago de Compostela (SERGAS), Santiago de Compostela, Spain. juan.ruiz.banobre@sergas.es.; Translational Medical Oncology Group (ONCOMET), Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Spain. juan.ruiz.banobre@sergas.es.; University of Santiago de Compostela (USC), Santiago de Compostela, Spain. juan.ruiz.banobre@sergas.es.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain. juan.ruiz.banobre@sergas.es. |
| Source: | BMC cancer [BMC Cancer] 2025 Nov 28; Vol. 25 (1), pp. 1835. Date of Electronic Publication: 2025 Nov 28. |
| Publication Type: | Journal Article; Multicenter Study |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
